Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).

Literature DB >> 22454798

Persistent Psychosis After a Single Ingestion of "Ecstasy" (MDMA).

Ankit Patel¹, Toby Moreland, Fasiha Haq, Fatima Siddiqui, Melissa Mikul, Huma Qadir, Shakeel Raza.

Abstract

Entities: Disease

Year: 2011 PMID： 22454798 PMCID： PMC3304680 DOI： 10.4088/PCC.11l01200

Source DB: PubMed Journal: Prim Care Companion CNS Disord ISSN： 2155-7780

× No keyword cloud information.

13 in total

1. Ecstasy in the brain: a model for neuroimaging.

Authors: Robin A Hurley; Liesbeth Reneman; Katherine H Taber
Journal: J Neuropsychiatry Clin Neurosci Date: 2002 Impact factor: 2.198

2. Chronic atypical psychosis associated with MDMA ("ecstasy") abuse.

Authors: F Schifano
Journal: Lancet Date: 1991-11-23 Impact factor: 79.321

Review 3. Ecstasy (MDMA): a review of its possible persistent psychological effects.

Authors: M J Morgan
Journal: Psychopharmacology (Berl) Date: 2000-10 Impact factor: 4.530

4. Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: "Ecstasy").

Authors: R S Cohen; J Cocores
Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 1997-05 Impact factor: 5.067

5. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors: J A Henry; K J Jeffreys; S Dawling
Journal: Lancet Date: 1992-08-15 Impact factor: 79.321

6. M.D.M.A. ("Ecstasy"); a case of possible drug-induced psychosis.

Authors: H Williams; D Meagher; P Galligan
Journal: Ir J Med Sci Date: 1993-02 Impact factor: 1.568

Review 7. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

Authors: E Gouzoulis-Mayfrank; J Daumann
Journal: Addiction Date: 2006-03 Impact factor: 6.526

Review 8. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Authors: R Thomasius; P Zapletalova; K Petersen; R Buchert; B Andresen; L Wartberg; B Nebeling; A Schmoldt
Journal: J Psychopharmacol Date: 2006-03 Impact factor: 4.153

9. Persistent Psychosis and Medical Complications After a Single Ingestion of MDMA "Ecstasy": A Case Report and Review of the Literature.

Authors: Mordecai N Potash; Kimberly A Gordon; Kristy L Conrad
Journal: Psychiatry (Edgmont) Date: 2009-07

Review 10. Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate.

Authors: Kelly M Smith; Lisa L Larive; Frank Romanelli
Journal: Am J Health Syst Pharm Date: 2002-06-01 Impact factor: 2.637

5 in total

1. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.

Authors: Ke Xu; John H Krystal; Yuping Ning; Da Chun Chen; Hongbo He; Daping Wang; Xiaoyin Ke; Xifan Zhang; Yi Ding; Yuping Liu; Ralitza Gueorguieva; Zuoheng Wang; Diana Limoncelli; Robert H Pietrzak; Ismene L Petrakis; Xiangyang Zhang; Ni Fan
Journal: J Psychiatr Res Date: 2014-12-24 Impact factor: 4.791